WallStreetZenWallStreetZen

NASDAQ: MLTX
Moonlake Immunotherapeutics Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Moonlake Immunotherapeutics earnings were -$259.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest MLTX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$69.7M, up 10.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MLTX reported annual earnings of -$230.3M, with 90% growth. The next MLTX earnings date is Aug 4, 2026.

MLTX earnings history

Current Revenue
$0.0
Current Earnings
-$259.5M
Current Profit Margin
0%

MLTX Return on Equity

Current Company
-86.4%
Current Industry
-141.9%
Current Market
13.5%
MLTX's Return on Equity (-86.4%)... subscribe to Premium to read more.
High Return on Equity Performance

MLTX Return on Assets

Current Company
-61.1%
Current Industry
-13.7%
MLTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MLTX announces earnings.

MLTX Return on Capital Employed

Current Company
-70.26%
Current Industry
-9.5%
MLTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MLTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MLTX-$245.81M-$259.47MN/A-$3.87
VIR-$425.53M-$442.72MN/A-$3.12
BCAX-$155.96M-$157.32MN/A-$2.78
AAPG-$160.60M-$182.22MN/A-$2.05
INVA$657.74M$504.34M+23.56%$7.20
View Top Biotech Stocks

MLTX earnings dates

Next earnings date
Aug 4, 2026

Moonlake Immunotherapeutics Earnings Reports & History FAQ

What were Moonlake Immunotherapeutics's earnings last quarter?

Moonlake Immunotherapeutics (NASDAQ: MLTX) reported Q1 2026 earnings per share (EPS) of -$0.98, up 55.56% year over year. Total MLTX earnings for the quarter were -$69.71 million. In the same quarter last year, Moonlake Immunotherapeutics's earnings per share (EPS) was -$0.63.

If you're new to stock investing, here's how to buy Moonlake Immunotherapeutics stock.

When does Moonlake Immunotherapeutics report earnings?

The next MLTX earnings date is Invalid Date. Add MLTX to your watchlist to be reminded of Moonlake Immunotherapeutics's next earnings date.

Is Moonlake Immunotherapeutics profitable or losing money?

As of the last Moonlake Immunotherapeutics earnings report, Moonlake Immunotherapeutics is currently losing money. Moonlake Immunotherapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$259.47 million, a 75.52% increase year over year.

What was MLTX's earnings growth in the past year?

As of Moonlake Immunotherapeutics's earnings date in Q2 2026, Moonlake Immunotherapeutics's earnings has grown year over year. MLTX earnings in the past year totalled -$259.47 million.

What are Moonlake Immunotherapeutics's earnings expectations?

The current EPS estimate for Moonlake Immunotherapeutics's earnings report in Invalid Date is -$0.93.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.